about
Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic miceFoxO1 mediates insulin-dependent regulation of hepatic VLDL production in miceInhibition of Foxo1 function is associated with improved fasting glycemia in diabetic miceFoxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblastsInsulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interactionProteomic analysis of fructose-induced fatty liver in hamstersIncreased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance.A role of apolipoprotein D in triglyceride metabolismEvolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout miceChallenges for gene therapy of type 1 diabetes.Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice.Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice.FoxO6 integrates insulin signaling with gluconeogenesis in the liver.Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.Central effects of humanin on hepatic triglyceride secretion.FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.FoxO6 in glucose metabolism (FoxO6)Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice.PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1Aberrant Forkhead box O1 function is associated with impaired hepatic metabolismFoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages.FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymphSMAD3/Stat3 Signaling Mediates β-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes.FoxO integration of insulin signaling with glucose and lipid metabolism.Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.Glucose-regulated insulin production in the liver improves glycemic control in type 1 diabetic miceImproved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.Elevated vascular endothelial growth factor production in islets improves islet graft vascularization.Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes.Sex- and Tissue-Specific Role of Estrogen Sulfotransferase in Energy Homeostasis and Insulin Sensitivity.APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated β Cell Aging in Pancreas-specific SMAD7 Mutant Mice.Effect of hepatic insulin expression on lipid metabolism in diabetic mice.FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic miceAngiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosisSirolimus is associated with reduced islet engraftment and impaired beta-cell functionDeficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistanceA Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes
P50
Q24302828-9A054D88-0BDE-4E3F-8126-278B7BFDFDAEQ28507512-DE9921AC-2C6E-4475-B303-9FDD7D605C6FQ28511006-D624C342-6CFF-45AD-A217-692319AE46CBQ28591040-3A560BA0-D97F-4D8A-908F-A9E75DBFFA00Q29619822-C423B84B-B083-4E5E-87E7-AD1D7BAD3EC2Q33353210-83759E92-6EF6-4682-A1E1-0DD1672B242AQ34389068-A831A369-A516-4D8F-8E6E-295FC88E5F6DQ34559829-816ED3D7-F009-4D3B-8918-A1ABC13E2938Q34730646-1B76133E-C58D-4EC4-AB96-2C5E696B02C3Q35023262-267DCE9B-C47C-4BE9-80D2-F026AA12048BQ35063215-4C7DFC9D-BF24-4738-8EFD-F8567DDE138FQ35266454-DD7834F4-51A2-4BC8-8D06-9E11D5653703Q35405206-69A38640-6D6D-40F7-83D3-947A38239050Q35860656-806EFA31-5F9F-4446-89C5-F6D81A9E90BBQ35916831-0033799E-EF7E-4F52-902F-79EF468FAFFBQ36625105-078FE007-818D-46DB-9FC7-9D4620C5A13AQ36854236-F78EE798-79CF-43E7-BA1C-3E5C440C7218Q37078689-B5C530BF-ED95-4A95-B576-603BAC2B7055Q37132127-B13C84A5-CF68-4639-B1D3-DF33ACA3E143Q37149423-AB9FDF94-34A4-49A6-8016-3E6F4FB60A0FQ37149810-FEFA7869-A17C-48C2-A3D4-AC2E5004BCADQ37400789-3741DA94-A56A-488A-A303-6337264C59DFQ37648011-C05AFE74-C08D-4A76-A790-3D2AA9065EF5Q37727877-2E242882-0F9F-4DEE-9A74-9E8EE24BAC34Q38642391-46143AC0-3578-4A75-8DEC-B6EB03B4780EQ39141439-A3037E66-66B0-406D-91D5-DD773124B1EAQ40301333-29B0CD82-A71B-4330-B8FD-43F3FDC0A539Q41429641-C937868D-8C26-4DF3-91A0-7F23F0DCC4E1Q44043194-68F6E2B8-8EA9-48C0-8E31-BC4A0E05B7CFQ44816724-22D13EEC-8142-46D7-9792-0697FAFEC7FFQ46268603-7A6A7B10-0DF8-491F-9FC8-7E8C8D38FC3EQ47630924-7FCE7265-FA12-4234-BC3E-E485A4C3BC7DQ51172839-0E7AF12D-E893-419D-B141-CAB326C52330Q51213864-59FAC0AA-BE5B-4347-A3AF-DFD540B699DAQ53551509-E2AECD18-3710-4903-A92E-C30DB2C4BF13Q64082459-F6E0C7A6-39F0-4B74-A557-6686F56B3683Q64377086-FC8C9042-E6E5-413C-BC51-1F4834B2AD55Q80175258-392926B0-7946-438C-BEFC-BD23DDA96BB8Q90070282-DD8920A1-4958-4215-BFCF-975D01E66D31Q91760095-15E94213-40B5-42C7-8592-DF51BE676B4D
P50
description
researcher
@en
name
Hengjiang Dong
@en
Hengjiang Dong
@nl
type
label
Hengjiang Dong
@en
Hengjiang Dong
@nl
prefLabel
Hengjiang Dong
@en
Hengjiang Dong
@nl
P108
P106
P31
P496
0000-0003-0279-5241